<DOC>
	<DOCNO>NCT02407977</DOCNO>
	<brief_summary>This observational study . This protocol determine feasibility use novel nano-material base fiber-optic dosimeter ( nanoFOD ) device , dimension less 1 mm wide , measure real-time , pin-point , in-vivo radiation dose give external beam delivery radiation therapy treatments.This new protocol similiar design Pro00050297 significant difference monitoring perform external baem radiotherapy .</brief_summary>
	<brief_title>Real Time In-Vivo Body Surface Dosimetry External Beam Radiation Therapy</brief_title>
	<detailed_description>The device currently use ongoing IRB approve protocol Pro00050297 `` Real Time In-Vivo Dosimetry For Gynecologic Brachytherapy '' . Brachytherapy integral part management many gynecological cancer , use radioactive isotope deliver radiation treatment close proximity target . The protocol use device set gynecologic brachytherapy monitor real time dos , primary endpoint feasibility accuracy . Accrual ongoing , however , device initially give consistent result , within 3 % expect value . This initial experience intentionally design simple geometry position . This protocol similar design initial brachytherapy trial , significant difference monitoring perform external beam radiotherapy . Calibration procedure different scenario , consideration dose monitor useful distinct consideration brachytherapy .</detailed_description>
	<criteria>Histologically document neoplasm pelvis ( include gynecologic , gastrointestinal , genitourinary origin ) . Planned external beam radiotherapy part standard care treatment The radiotherapy plan involve body surface Age &gt; 18 year Able provide execute informed consent Allergy previous intolerance skin adhesives Any clinical scenario nanoFOD placement reading would compromise treatment efficacy , endanger patient way .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>